Table 2. Results of gonadal hormone levels: effects of group, genotype and menstrual cycle phase.
| PDM | Control | p Value | |||||
|---|---|---|---|---|---|---|---|
| AA | G carrier | AA | G carrier | Phase | Group | Genotype | |
| (n = 26) | (n = 35) | (n = 23) | (n = 42) | ||||
| Estradiol (pg/mL) | |||||||
| Menstruation | 32.9 (14.12) | 33.4 (17.89) | 30.2 (15.53) | 37.2 (17.96) | 0.000 | 0.653 | 0.166 |
| Peri-ovulatory phase | 146.9 (84.23) | 157.5 (115.81) | 151.8 (132.23) | 142.8 (114.04) | 0.370 | 0.770 | |
| Progesterone (ng/mL) | |||||||
| Menstruation | 0.5 (0.46) | 0.4 (0.25) | 0.9 (2.50) | 0.5 (0.30) | 0.007 | 0.396 | 0.857 |
| Peri-ovulatory phase | 0.9 (1.38) | 0.7 (0.79) | 1.9 (3.23) | 1.3 (2.78) | 0.709 | 0.625 | |
| Testosterone (ng/mL) | |||||||
| Menstruation | 0.4 (0.28) | 0.3 (0.17) | 0.4 (0.22) | 0.4 (0.22) | 0.000 | 0.830 | 0.743 |
| Peri-ovulatory phase | 0.5 (0.37) | 0.5 (0.23) | 0.4 (0.24) | 0.5 (0.18) | 0.862 | 0.707 | |
The data are presented as the means (SD). PDM, primary dysmenorrhea.